Answers are grounded in this paper and cite their sources.
Background: Type 2 diabetes mellitus (T2DM) increases the risk of ischemic stroke, yet their shared transcriptional mechanisms remain incompletely understood. Objective: This study aimed to identify shared differentially expressed genes (DEGs), enriched biological pathways, and candidate hub genes associated with T2DM and ischemic stroke. Methods: Blood-derived transcriptomic datasets GSE21321 (nine T2DM patients and eight controls) and GSE16561 (39 ischemic stroke patients and 24 controls) were independently analyzed. DEGs were identified using an adjusted P value < 0.05 and an absolute log2 fold change ≥ 0.5. Concordantly dysregulated genes underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Protein–protein interaction (PPI) networks were constructed using STRING, and hub genes were ranked using Maximal Clique Centrality (MCC). Results: A total of 624 DEGs were identified in T2DM and 817 in ischemic stroke, with 46 shared genes. Among these, 28 were upregulated, 12 downregulated, and six showed discordant expression. The 40 concordant genes were enriched in neutrophil activation, cytokine signaling, oxidative stress, and inflammatory pathways, including TNF, NF-κB, and Toll-like receptor signaling. The PPI network contained 40 nodes and 112 edges, identifying IL1B, TLR4, S100A9, S100A8, and MMP9 as leading hub genes. Conclusion: T2DM and ischemic stroke share transcriptional signatures involving innate immunity, inflammation, and vascular-associated processes. External validation and experimental studies are required to establish causal relevance and biomarker potential.
No takes yet. Share an insight, caveat, or question.
Pranandi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: